E

Exosome Diagnostics

84 employees

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
diagnostic development
Health Care
biomarkers
Genetics
biofluids
exosomes and microvesicles

Date founded

2008

Funding rounds raised

Total raised

$30M

from 17 investors over 17 rounds

E

Exosome Diagnostics raised $30M on July 24, 2017

Investors: Blue Ridge Investment Co, Forbion, ARCUS VENTURES LTD, Tiger Infrastructure Partners and b-to-v Partners AG

E

Exosome Diagnostics raised $16M on January 7, 2016

Investors: Forbion, Blue Ridge Investment Co, QIAGEN and ARCUS VENTURES LTD

E

Exosome Diagnostics raised $18M on September 2, 2015

Investors: Forbion and ARCUS VENTURES LTD

E

Exosome Diagnostics raised $27M on March 11, 2014

Investors: b-to-v Partners AG, Forbion, ARCUS VENTURES LTD, QIAGEN and Tiger Infrastructure Partners

E

Exosome Diagnostics raised $20M on May 11, 2010

Investors: Forbion

FAQ